(Q35638002)

9 August 2017

1 reference

title

Single versus combined antibiotic therapy for gram-negative infections (English)

1 reference

9 August 2017

Gram-negative bacteria

0 references

author name string

Olga M Klibanov

series ordinal

1

1 reference

9 August 2017

Ralph H Raasch

series ordinal

2

1 reference

9 August 2017

John C Rublein

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

19 December 2003

1 reference

Annals of Pharmacotherapy

9 August 2017

1 reference

9 August 2017

38

1 reference

9 August 2017

2

1 reference

9 August 2017

332-337

1 reference

Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci

9 August 2017

1 reference

Penicillin-Aminoglycoside Synergy in Experimental Streptococcus viridans Endocarditis

21 January 2018

1 reference

Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa

21 January 2018

1 reference

Ciprofloxacin, imipenem and rifampicin: in-vitro synergy of two and three drug combinations against Pseudomonas cepacia.

21 January 2018

1 reference

Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex.

21 January 2018

1 reference

In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa

21 January 2018

1 reference

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods.

21 January 2018

1 reference

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

21 January 2018

1 reference

Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.

21 January 2018

1 reference

Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia

21 January 2018

1 reference

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D132

1 reference

9 August 2017

1 reference